MIT Biotechnology Group

Science to Spinoff seminar Mar 11, 4P, 32-124

Eager to learn how to turn exciting science and technologies discovered and developed in a lab into a successful MIT spinoff? Interested in hearing insights from a prolific entrepreneur and leader with 20 years of experience as a CEO building startup and early-stage novel therapeutic platform companies? 

 Join us for MBG’s Science to Spinoff seminar, featuring Elicio Therapeutics scientific founder Prof. Darrell Irvine and CEO Mr. Robert Connelly. Elicio uses an amphiphile platform technology developed in the lab of Prof. Irvine to precisely deliver immunogens to the lymphatic system, and thereby orchestrating an immune response to aggressive cancers. Since its establishment in 2019, Elicio has secured more than $60M to develop therapeutic cancer vaccines.

Please RSVP here:

Leave a Reply